Skyline Medical Reports Third Quarter 2016 Financial Results

November 15, 2016

MINNEAPOLIS, Nov. 15, 2016, SKLN, (GLOBE NEWSWIRE) Skyline Medical Inc. (SKLN) (“Skyline” or “the Company”), developer of the innovative STREAMWAY® waste fluid disposal system for medical applications, reports financial results for the three and nine months ended September 30, 2016. Highlights of the third quarter of 2016 and recent weeks include: Signed an agreement with GLG Pharma, Inc. to be the exclusive distributor of the STREAMWAY System in the U.K., Poland and certain Central European countries Entered into a
http://bit.ly/2gdpiLL


Skyline Medical and GLG Pharma Enter into Partnership to Develop Diagnostic Tests for Skyline’s STREAMWAY System

October 31, 2016

Skyline to be exclusive reseller MINNEAPOLIS, Sept. 21, 2016, SKLN, (GLOBE NEWSWIRE) Skyline Medical Inc. (NASDAQ:SKLN) (“Skyline” or “the Company”), producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, announces the signing of a partnership and exclusive reseller agreement with GLG Pharma, LLC (“GLG”). Under the terms of the agreement, GLG intends to develop rapid diagnostic tests that utilize fluid and tissue collected by the STREAMWAY System during procedures. Skyline Medical will issue common stock to
http://bit.ly/2e5LUrZ


Skyline Medical Appoints J. Melville Engle and Timothy A. Krochuk to its Board of Directors

October 27, 2016

MINNEAPOLIS, Oct. 27, 2016, SKLN, (GLOBE NEWSWIRE) Skyline Medical Inc. (NASDAQ:SKLN) (“Skyline” or “the Company”), producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, announces the appointments of Timothy A. Krochuk and J. Melville (“Mel”) Engle to its Board of Directors, effective as of today. These appointments increase the number of Directors to five, all of whom are independent directors. “We are delighted to welcome such talented and experienced professionals as Tim and Mel to the
http://bit.ly/2fkVITS